Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,388 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07027072RecruitingPhase 2
Testing KDS2010 for early Alzheimer's memory loss
This study tests a new drug called KDS2010 for people with early Alzheimer's or mild memory loss. It aims to see if the drug can slow thinking and memory decline. You will need a caregiver to help with visits and must have a special brain scan showing amyloid plaques.
Gwangju, GwangjuAges 50–85 - NCT07027280Recruiting
Measuring Tumor Differences in Head and Neck Cancer
This study uses scans and tissue samples to look at differences within your tumor (called heterogeneity). It may help doctors understand your cancer better and choose the best treatment approach.
ChongqingAges 15–89 - NCT07028580Recruiting
High-Protein Plant Diet for Liver Cirrhosis
This study tests whether a special diet high in plant-based protein (with some animal protein) can help people with severe liver cirrhosis who are waiting for a kidney transplant. The diet aims to improve nutrition and health without overloading the liver.
Athens, AtticaAges 18–80 - NCT07028762Recruiting
Catching skills study for preschoolers with motor challenges
This study looks at catching skills in boys aged 4 to 7 who have some motor coordination issues. The goal is to understand and help improve their catching abilities.
Pardubice, Česká RepublikaAges 4–7 - NCT07029126Recruiting
Fremanezumab for migraine with depression: caregiver impact study
This trial tests if fremanezumab, a migraine prevention drug, can also reduce the stress and improve the relationship between migraine patients with mild depression and their caregivers. If you or someone you care for has migraines and low mood, this study may help understand how the caregiver is affected.
Rome, ItalyAges 18 years+ - NCT07029334Recruiting
Effectiveness of Social Prescribing
This study looks at how well social prescribing works. Social prescribing connects you with community activities or support to improve your health and well-being. Everyone who takes part in the social prescribing program can join this evaluation.
CopenhagenAges 18 years+ - NCT07029802Recruiting
Body awareness study for adults with spinal cord injury
This study looks at how people with spinal cord injury (SCI) feel and picture their bodies. If you have had an SCI for one year or longer, you may help doctors better understand and measure this sense of body awareness.
Minneapolis, MinnesotaAges 18 years+ - NCT07030907RecruitingPhase 1
Testing OPB-101 for platinum-resistant ovarian cancer
This trial tests a new treatment called OPB-101 for people with a type of ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum chemotherapy. The goal is to see if it is safe and if it can help shrink or slow the cancer.
Detroit, MichiganAges 18 years+ - NCT07032688RecruitingPhase 1
Study of SHR-3167 for type 2 diabetes
This trial tests an experimental drug called SHR-3167 in people with type 2 diabetes. The goal is to see how the drug works in the body and how it affects blood sugar. It may be an option for adults who have had diabetes for at least 6 months.
Chengdu, SichuanAges 18–59 - NCT07033026RecruitingPhase 2
Study of NGM120 for weight loss in colorectal cancer
This study tests an experimental drug called NGM120 for people with colorectal cancer who are losing weight (a condition called cancer cachexia). It is a placebo-controlled trial, meaning some participants will receive the drug and some will receive a placebo, to see if the drug helps stop or reverse this weight loss.
Los Angeles, CaliforniaAges 18 years+ - NCT07033117Recruiting
Improving kidney transplant access with RaDIANT
This trial tests if a special program helps dialysis centers refer more people to large transplant centers for a kidney transplant.
Atlanta, GeorgiaAges 18–80 - NCT07033234RecruitingPhase 1
Safety study of HS-20118 in healthy volunteers and psoriasis patients
This study tests a new oral medication (HS-20118) for safety and how it works in the body. It is for healthy volunteers or people with chronic plaque psoriasis, and will help see if the drug is safe and how it behaves with or without food.
Hangzhou, ZhejiangAges 18–65 - NCT07034014Recruiting
Study of three new bandage types on healthy skin
This study tests three experimental bandages to see how well they stick and feel on the back. You may qualify if you have healthy skin and are willing to follow some simple rules about washing and lotions.
Schenefeld, Free and Hanseatic City of HamburgAges 18–70 - NCT07034391RecruitingPhase 2
PD-1 inhibitor with denosumab and chemo for advanced lung cancer
This trial tests a combination of an immunotherapy drug (PD-1 inhibitor), a bone-strengthening drug (denosumab), and chemotherapy for people with advanced or spread non-squamous non-small cell lung cancer that does not have certain genetic changes. The goal is to see if this combination helps shrink tumors and control the disease.
Shenyang, LiaoningAges 18–75 - NCT07034690RecruitingPhase 4
Better cholesterol control for high-risk patients
This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.
Abu DhabiAges 18–100 - NCT07035028Recruiting
Scalp stimulation test for baby's oxygen levels during labor
This trial tests a simple, non-invasive scalp stimulation on your baby's head during labor to see if it can predict whether your baby is getting enough oxygen, potentially avoiding the need for a more invasive blood test.
MadridAges 18–50 - NCT07035106Recruiting
Using wearables to track recovery after ICU
This study tests if a wearable device and health summaries can help people recover after a stay in the intensive care unit (ICU). It is for people who have diabetes or heart problems and left the ICU within the last 2 years.
ViennaAges 18–65 - NCT07035769RecruitingPhase 1
Debio 1453P safety study in healthy adults
This trial tests an experimental oral drug, Debio 1453P, for the first time in people. Healthy adults can take part to see if the drug is safe and how the body processes it.
EdegemAges 18–55 - NCT07035925Recruiting
Testing a hydrogel for treating anal fistulas
This trial tests a hydrogel made from natural materials to help heal a specific type of anal fistula. It may be an option if you have a single high transsphincteric fistula with a seton in place for at least four weeks.
Lebanon, New HampshireAges 18 years+ - NCT07036133RecruitingPhase 1
Study of Pralatrexate in patients with advanced cancer and liver problems
This trial tests a drug called pralatrexate in people with advanced solid tumors or blood cancers, including those with different levels of liver function. The goal is to understand how the drug works in the body and how safe it is for patients with various degrees of liver impairment.
Cerritos, CaliforniaAges 18 years+ - NCT07036146Recruiting
Study of S100B changes after head trauma in the ER
This study looks at changes in a protein called S100B in people who come to the emergency room with a head injury. It is an observational study, meaning no treatment is given; researchers just take blood samples to see how S100B levels change, which might help doctors better understand head injuries.
Milan, MilanoAges Up to 100 years - NCT07036575Recruiting
Easy-to-Read Content Study for Kids with Learning Challenges
This study tests if easy-to-read materials help children with intellectual disabilities understand health information better. It may benefit kids who have trouble with regular reading materials.
TaipeiAges 3–17 - NCT07036770Recruiting
Heart artery check with new CT and camera inside arteries
This trial tests a new CT scanner (photon-counting CT) combined with a tiny camera inside the heart arteries to better see blockages. It's for people with chest pain or silent ischemia, but not for those having a big heart attack (STEMI) or with unstable conditions.
LeuvenAges 18 years+ - NCT07037472Recruiting
Imaging calcium deposits in dermatomyositis patients
This study uses a special imaging technique (photoacoustic/ultrasound) to look at calcium deposits under the skin in people with dermatomyositis. It aims to find patterns that help doctors understand the condition and track how well treatments work.
BeijingAges 18–80
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,388 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.